Cargando…

Cyclophosphamide-Induced Tolerance in Allogeneic Transplantation: From Basic Studies to Clinical Application

Immune tolerance against alloantigens plays an important role in the success of clinical organ and allogeneic hematopoietic stem cell transplantation. The mechanisms of immune tolerance to alloantigens have gradually been elucidated over time. Although there have been numerous reports to date on the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kato, Koji, Takeuchi, Ario, Akashi, Koichi, Eto, Masatoshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7005582/ https://www.ncbi.nlm.nih.gov/pubmed/32082305 http://dx.doi.org/10.3389/fimmu.2019.03138

Ejemplares similares

A Review of Cyclophosphamide-Induced Transplantation Tolerance in Mice and Its Relationship With the HLA-Haploidentical Bone Marrow Transplantation/Post-Transplantation Cyclophosphamide Platform
por: Mayumi, Hisanori
Publicado: (2021)

Interleukin-6 as Biomarker for Acute GvHD and Survival After Allogeneic Transplant With Post-transplant Cyclophosphamide
por: Greco, Raffaella, et al.
Publicado: (2019)

Clinical and Basic Research Progress on Treg-Induced Immune Tolerance in Liver Transplantation
por: Ni, Xuhao, et al.
Publicado: (2021)

Editorial: Immune Tolerance Post Allogeneic Hematopoietic Cell Transplantation
por: Schneidawind, Dominik, et al.
Publicado: (2020)

Is there any difference between busulfan-cyclophosphamide and cyclophosphamide-busulfan in patients underwent allogeneic transplantation?
por: Bahçecioğlu, Ömer Faruk, et al.
Publicado: (2021)

Use of Post-transplant Cyclophosphamide Treatment to Build a Tolerance Platform to Prevent Liquid and Solid Organ Allograft Rejection
por: Lightbourn, Casey O., et al.
Publicado: (2021)

Intestinal Microbiota Influence Immune Tolerance Post Allogeneic Hematopoietic Cell Transplantation and Intestinal GVHD
por: Köhler, Natalie, et al.
Publicado: (2019)

Early Cardiac Toxicity Associated With Post-Transplant Cyclophosphamide in Allogeneic Stem Cell Transplantation
por: Duléry, Rémy, et al.
Publicado: (2021)

Cytotoxic Pathways in Allogeneic Hematopoietic Cell Transplantation
por: Du, Wei, et al.
Publicado: (2018)

Progress in Liver Transplant Tolerance and Tolerance-Inducing Cellular Therapies
por: Du, Xiaoxiao, et al.
Publicado: (2020)

Case report: HLA-haploidentical hematopoietic cell transplant with posttransplant cyclophosphamide in a patient with leukocyte adhesion deficiency type I
por: Yamashita, Motoi, et al.
Publicado: (2022)

Immune reconstitution profile after allogeneic hematopoietic stem cell transplantation with post-transplant cyclophosphamide
por: Espinoza-Gutarra, Manuel, et al.
Publicado: (2023)

Cytokine-Induced Memory-Like NK Cells: From the Basics to Clinical Applications
por: Terrén, Iñigo, et al.
Publicado: (2022)

Post-transplantation Cyclophosphamide: From HLA-Haploidentical to Matched-Related and Matched-Unrelated Donor Blood and Marrow Transplantation
por: Williams, Louis, et al.
Publicado: (2020)

The Clinical Value of Procalcitonin in the Neutropenic Period After Allogeneic Hematopoietic Stem Cell Transplantation
por: Shan, Meng, et al.
Publicado: (2022)

Autologous and Allogenous Antibodies in Lung and Islet Cell Transplantation
por: Nayak, Deepak Kumar, et al.
Publicado: (2016)

Autoimmunity Following Allogeneic Hematopoietic Stem Cell Transplantation
por: Buxbaum, Nataliya Prokopenko, et al.
Publicado: (2020)

Allogeneic Hemopoietic Stem Cell Transplantation for Myelofibrosis: 2021
por: Bacigalupo, Andrea, et al.
Publicado: (2021)

Panuveitis induced by donor-derived CD8(+) T cells after allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia
por: Takeda, Atsunobu, et al.
Publicado: (2022)

Efficacy and Safety of Aprepitant in Allogeneic Hematopoietic Stem Cell Transplantation
por: Uchida, Mayako, et al.
Publicado: (2013)

Mechanisms of Graft-versus-Host Disease Prevention by Post-transplantation Cyclophosphamide: An Evolving Understanding
por: Nunes, Natalia S., et al.
Publicado: (2019)

Busulfan-cyclophosphamide versus cyclophosphamide-busulfan as conditioning regimen before allogeneic hematopoietic cell transplantation: a prospective randomized trial
por: Seydoux, Claire, et al.
Publicado: (2020)

Strategies for Deliberate Induction of Immune Tolerance in Liver Transplantation: From Preclinical Models to Clinical Application
por: Tanimine, Naoki, et al.
Publicado: (2020)

Haploidentical Hematopoietic Stem Cell Transplantation Followed by ‘Post-Cyclophosphamide’: The Future of Allogeneic Stem Cell Transplant
por: Cytryn, Samuel, et al.
Publicado: (2020)

Impact of allogeneic stem cell transplantation comorbidity indexes after haplotransplant using post‐transplant cyclophosphamide
por: Jullien, Maxime, et al.
Publicado: (2021)

Immune Reconstitution after Allogeneic Hematopoietic Stem Cell Transplantation
por: Ogonek, Justyna, et al.
Publicado: (2016)

Antibody based conditioning for allogeneic hematopoietic stem cell transplantation
por: Saha, Asim, et al.
Publicado: (2022)

Allogeneic hematopoietic stem cell transplantation in the COVID-19 era
por: Bordat, Jonathan, et al.
Publicado: (2023)

The impact of epigenetic modifications on allogeneic hematopoietic stem cell transplantation
por: Ktena, Yiouli P., et al.
Publicado: (2023)

The two-step approach to allogeneic hematopoietic stem cell transplantation
por: Ibikunle, Sikemi, et al.
Publicado: (2023)

Cardiac toxicity after matched allogeneic hematopoietic cell transplant in the posttransplant cyclophosphamide era
por: Yeh, Jason, et al.
Publicado: (2021)

Impact on early outcomes and immune reconstitution of high-dose post-transplant cyclophosphamide vs anti-thymocyte globulin after reduced intensity conditioning peripheral blood stem cell allogeneic transplantation
por: Retière, Christelle, et al.
Publicado: (2018)

Extracellular Vesicles as Biomarkers of Acute Graft-vs.-Host Disease After Haploidentical Stem Cell Transplantation and Post-Transplant Cyclophosphamide
por: Lia, Giuseppe, et al.
Publicado: (2022)

Clinical Utility of the Detection of the Loss of the Mismatched HLA in Relapsed Hematological Patients After Haploidentical Stem Cell Transplantation With High-Dose Cyclophosphamide
por: Muñiz, Paula, et al.
Publicado: (2021)

Extracellular Vesicles After Allogeneic Hematopoietic Cell Transplantation: Emerging Role in Post-Transplant Complications
por: Lia, Giuseppe, et al.
Publicado: (2020)

HLA-C Incompatibilities in Allogeneic Unrelated Hematopoietic Stem Cell Transplantation
por: Tiercy, Jean-Marie
Publicado: (2014)

Pre-emptive Allogeneic Hematopoietic Stem Cell Transplantation in Ataxia Telangiectasia
por: Bakhtiar, Shahrzad, et al.
Publicado: (2018)

Novel Biomarkers for Outcome After Allogeneic Hematopoietic Stem Cell Transplantation
por: Chen, Sophia, et al.
Publicado: (2020)

Management of Hepatitis B Virus in Allogeneic Hematopoietic Stem Cell Transplantation
por: Wu, Yibo, et al.
Publicado: (2021)

A Model of Minor Histocompatibility Antigens in Allogeneic Hematopoietic Cell Transplantation
por: Martin, Paul J., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_si7igg8nfbcjg6vcdr0233eanq